Mondello, P., Steiner, N., Willenbacher, W., Cerchione, C., Nappi, D., Mauro, E., . . . Mian, M. (2018). Bendamustine plus Rituximab Versus R‐CHOP as First‐Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Oncologist.

Mondello, Patrizia, Normann Steiner, Wolfgang Willenbacher, Claudio Cerchione, Davide Nappi, Endri Mauro, Simone Ferrero, Salvatore Cuzzocrea, ja Michael Mian. "Bendamustine Plus Rituximab Versus R‐CHOP As First‐Line Treatment for Patients With Follicular Lymphoma Grade 3A: Evidence From a Multicenter, Retrospective Study." Oncologist 2018.

Mondello, Patrizia, et al. "Bendamustine Plus Rituximab Versus R‐CHOP As First‐Line Treatment for Patients With Follicular Lymphoma Grade 3A: Evidence From a Multicenter, Retrospective Study." Oncologist 2018.